Rowena Almeida

[Ramon Bataller @rabataller]

This large study has a positive result that needs to be highlighted:

CONSULTING AN ADDICTION SPECIALIST DECREASES MORTALITY IN ALCOHOL-ASSOCIATED HEPATITIS.

We must do it.

https://t.co/4GY3Eyfqmm

[GI Pearls @GI_Pearls]

Thank goodness!! #gitwitter #livertwitter. Just like @ebtapper taught me, when I was green.

[LiverTox @livertox]

Wow.! LiverTox now has information on over 1400 drugs and herbal products described in 1290 different chapters with more than 3 million words and 34,000 annotated references. #livertwitter REPOST if you sue LiverTox and find it useful

[Henry E. Chang @HenryEChang]

Large meta-analysis reveals sequential NITs like FIB-4 or NFS, followed by LSM-VCTE, match the diagnostic performance of LSM-VCTE alone for #MASH screening. This cost-effective strategy reduces screen failures and biopsies in clinical trials, making a significant advance in identifying patients at high risk of MASH+F-2 and MASH+F4→https://t.co/G8lNTEmtPp via @m__ferenc @ValiYasaman @JeromeBoursier @ProfYusufYilmaz @VWSWong @annelindemak @HannesHagstrom @docberza @NoureddinMD @CarlaYunis @QAnstee @pmmbossuyt @LiverInt #MASLD #NAFLD #NASH #livertwitter

[Elliot Tapper @ebtapper]

The diagnosis of autoimmune hepatitis is tough!

Autoantibodies can be suggestive but to be honest they rarely clinch or rule out the diagnosis. Biopsy is helpful - unless it isn’t. In the end, it comes down to shared decisions and time

Into this fray a new paper

[Juan Turnes @jturnesv]

👋 Repeat with me:

Ammonia determination is NOT useful for the diagnosis of hepatic encephalopathy

By the great @JasmohanBajaj 👇

#TLM23 #livertwitter

[InaNP @inakantorovich]

I'm so incredibly proud of my colleague who shined at The Liver Meeting, advocating passionately for patients with alcohol-related liver disease. ⁦@AASLDtweets⁩ ⁦@AASLDFoundation⁩ ⁦@LizLeeNP⁩ ⁦@AutoImmuneLiver⁩⁩ ⁦⁦@hepatoMD⁩ @zee_joanne⁩

[Elliot Tapper @ebtapper]

Common question: How fast do we need to give steroids for alcoholic hepatitis?

1⃣Not fast. No door-to-pred time. See the STOPAH protocol below. Make sure it is safe.
2⃣No need. Few will benefit, many will be harmed. Choose carefully.

#livertwitter

[Elliot Tapper @ebtapper]

The hepatologist’s CBC

[Elliot Tapper @ebtapper]

Assessing the risk of surgery in patients with cirrhosis

I find myself referring to this @HepCommJournal paper by Kaltenbach and Mahmud. Turns out it has been read 1100 times in the last 4 months!!

#livertwitter
Open access https://t.co/bLXYtBYepv

[👩‍⚕️ Dr. Laura 👩‍⚕️ @datadriven_tdoc]

🌟🌟How does this compare to other therapies for UC?

➡️UST/UPA trials had similar design
➡️➡️marginal gains numerically over UST
➡️➡️UPA appears meaningfully more efficacious than both UST and MIRI

➡️ not compared to VDZ or anti-TNFs; trial designs/pt. pops are very different

[Manuel Mendizabal @MMendizabalMD]

Naltrexone appears to be safe and effective in maintaining abstinence and decreasing craving in patients with cirrhosis who were actively drinking.

Well designed study addressing a very relevant topic.
#EASLCongress

[Gastroenterology Review @GIreview]

Update in the Treatment of the Complications of Cirrhosis - Clinical Gastroenterology and Hepatology https://t.co/2lD4HCTHrp

[Samir C. Grover, M.D. @Samir_Grover]

How to academic staff on call, a thread

who knows if any of this is good - mainly this is how I try to show appreciation for the mega privilege I have as an academic doc #medtwitter #gitwitter #meded

I learned from the best, pic related @PD_Perls @DrRonWald @DarrenYuen1

[Elliot Tapper @ebtapper]

Bookmark this: Assessing the risk of surgery in patients with cirrhosis

https://t.co/K1jYSP7jYh

Authoritative. Useful. #livertwitter

From Kaltenbach and Nadim “https://t.co/TT42LBxpi2” Mahmud

[Elliot Tapper @ebtapper]

Statin induced liver injury is super rare. Consider it but dont close your mind to other possibilities.

If you want rates of injury, just ask @bjornsson_s who studied the Swedish national register in this @JHepatology paper. https://t.co/vptZM9a57b

[Dr. Shazma Mithani @DrShazmaMithani]

Hey @ianhanomansing and @checkupcbc there are a few things I wanted to address about the recent episode on private healthcare clinics. I called in and went through screening, but unfortunately didn’t make it onto the show.

A thread 🧵 /1

[Juan Pablo (JP) Arab, MD  @juanpabloarab]

@AtoosaRabiee @AdalGuzmanMD @GiJournal @LiverFellow @JHepatology @2pm @HershShroff @ParitaPatelMD @adam_c_winters @AlexSVogel @ebtapper @rabataller @mqkMD @DrLiver @drkeithsiau @nadimmahmud @LizzieAbyMD @SultanMahmoodMD @AASLDtweets Age certainly plays a role, because NAFLD is, in most cases, a slowly progressing disease. Approx. 1 fibrosis stage every 3-5y.
https://t.co/A1wBi1AWjr
#GIJC

[Gail Gazelle, MD, MCC @GailGazelleMD]

We often think that our notes need to be stellar as proof of our worthiness as a physician.

The reality is that the note is just a note.

Accept reality.
Save time.
Reclaim your life.

[Gail Gazelle, MD, MCC @GailGazelleMD]

Front story tip #1: We're not writing a NY Times bestseller here. Keep your notes brief and to the point. Imperfection is perfect. Haiku, not war and peace.